Effect of ethanol on insulin-like growth factor-II release from fetal organs

H. J. Mauceri, W. H. Lee, S. Conway

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

This study examines the effect of ethanol (ETOH) exposure and nutrient restriction on the release of insulin-like growth factor (IGF)-II from 18- and 20-day explanted fetal organs. Fetuses were exposed to ETOH (E) in utero by feeding dams a 36% (calories derived from ETOH: 6.6% v/v) ETOH liquid diet. Control fetuses were offsprings of dams either pair-fed (P) a control liquid diet or ad libitum (A) fed a standard pelleted lab chow. Brain, heart, kidney, liver, lung, muscle, and placenta of fetuses from the same litter were pooled and explanted, and IGF-II concentration in explanted media was analyzed by radioimmunoassay. Maternal and fetal weights were determined during pregnancy and at sacrifice, respectively, to evaluate the influence of ETOH on growth. Both maternal and fetal weights were substantially reduced by ETOH on 18 and 20 days of gestation compared with both A and P controls. At 18 days of gestation, E fetuses (1.33 ± 0.03 g) weighed less than either A (1.47 ± 0.03 g) or P (1.54 ± 0.04 g) fetuses. By 20 days, A mean fetal weight (4.19 ± 0.23 g) was significantly greater than both P (3.74 ± 0.06 g) and E (3.28 ± 0.06 g) fetuses. IGF-II concentration in media from 18-day fetal explants was highest from E (brain, heart, liver, and placenta) and P tissues (kidney, lung, and muscle). IGF-II in media from A tissues (except placenta) was lower than both E and P levels. A significant difference between treatments occurred in heart. By 20 days, IGF-II levels were highest in media from all A tissues (except placenta). IGF-II in media from E tissues (except lung) was lower than those from P tissues. A significant difference between treatments occurred in the brain. With regard to the developmental pattern, IGF-II release generally increased between 18 and 20 days of gestation, with the greatest increases occurring in A tissues. Increased secretion by P tissues was greater than that by corresponding E tissues, and tended to follow the A trend. On the other hand, E brain, kidney, and placenta released only slightly more IGF-II at 20 days compared to 18 days, whereas E heart, liver, lung, and muscle released slightly less hormone. This study suggests that even moderate nutrient deprivation influences the pattern of IGF-II release from fetal organs, even though there is only a small decrease in overall body size. At the same level of nutrient deprivation, ETOH more dramatically alters both fetal weight and the pattern of IGF-II release. Because IGFs are autocrine/paracrine factors that influence growth, differentiation, and function, the reduced availability of IGF-II may be one of the factors contributing to ETOH-induced growth retardation and impaired functional capacity of some organ systems.

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalAlcoholism: Clinical and Experimental Research
Volume18
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor II
Ethanol
Tissue
Fetal Weight
Fetus
Placenta
Brain
Liver
Nutrients
Muscle
Pregnancy
Lung
Nutrition
Kidney
Food
Muscles
Dams
Mothers
Growth Differentiation Factors
Diet

Keywords

  • Ethanol
  • Fetal Growth
  • Hormones
  • IGF-II
  • Organ Explants

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology

Cite this

Effect of ethanol on insulin-like growth factor-II release from fetal organs. / Mauceri, H. J.; Lee, W. H.; Conway, S.

In: Alcoholism: Clinical and Experimental Research, Vol. 18, No. 1, 1994, p. 35-41.

Research output: Contribution to journalArticle

Mauceri, H. J. ; Lee, W. H. ; Conway, S. / Effect of ethanol on insulin-like growth factor-II release from fetal organs. In: Alcoholism: Clinical and Experimental Research. 1994 ; Vol. 18, No. 1. pp. 35-41.
@article{136fb6e81bf94534bfe36e4819248fbc,
title = "Effect of ethanol on insulin-like growth factor-II release from fetal organs",
abstract = "This study examines the effect of ethanol (ETOH) exposure and nutrient restriction on the release of insulin-like growth factor (IGF)-II from 18- and 20-day explanted fetal organs. Fetuses were exposed to ETOH (E) in utero by feeding dams a 36{\%} (calories derived from ETOH: 6.6{\%} v/v) ETOH liquid diet. Control fetuses were offsprings of dams either pair-fed (P) a control liquid diet or ad libitum (A) fed a standard pelleted lab chow. Brain, heart, kidney, liver, lung, muscle, and placenta of fetuses from the same litter were pooled and explanted, and IGF-II concentration in explanted media was analyzed by radioimmunoassay. Maternal and fetal weights were determined during pregnancy and at sacrifice, respectively, to evaluate the influence of ETOH on growth. Both maternal and fetal weights were substantially reduced by ETOH on 18 and 20 days of gestation compared with both A and P controls. At 18 days of gestation, E fetuses (1.33 ± 0.03 g) weighed less than either A (1.47 ± 0.03 g) or P (1.54 ± 0.04 g) fetuses. By 20 days, A mean fetal weight (4.19 ± 0.23 g) was significantly greater than both P (3.74 ± 0.06 g) and E (3.28 ± 0.06 g) fetuses. IGF-II concentration in media from 18-day fetal explants was highest from E (brain, heart, liver, and placenta) and P tissues (kidney, lung, and muscle). IGF-II in media from A tissues (except placenta) was lower than both E and P levels. A significant difference between treatments occurred in heart. By 20 days, IGF-II levels were highest in media from all A tissues (except placenta). IGF-II in media from E tissues (except lung) was lower than those from P tissues. A significant difference between treatments occurred in the brain. With regard to the developmental pattern, IGF-II release generally increased between 18 and 20 days of gestation, with the greatest increases occurring in A tissues. Increased secretion by P tissues was greater than that by corresponding E tissues, and tended to follow the A trend. On the other hand, E brain, kidney, and placenta released only slightly more IGF-II at 20 days compared to 18 days, whereas E heart, liver, lung, and muscle released slightly less hormone. This study suggests that even moderate nutrient deprivation influences the pattern of IGF-II release from fetal organs, even though there is only a small decrease in overall body size. At the same level of nutrient deprivation, ETOH more dramatically alters both fetal weight and the pattern of IGF-II release. Because IGFs are autocrine/paracrine factors that influence growth, differentiation, and function, the reduced availability of IGF-II may be one of the factors contributing to ETOH-induced growth retardation and impaired functional capacity of some organ systems.",
keywords = "Ethanol, Fetal Growth, Hormones, IGF-II, Organ Explants",
author = "Mauceri, {H. J.} and Lee, {W. H.} and S. Conway",
year = "1994",
language = "English (US)",
volume = "18",
pages = "35--41",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Effect of ethanol on insulin-like growth factor-II release from fetal organs

AU - Mauceri, H. J.

AU - Lee, W. H.

AU - Conway, S.

PY - 1994

Y1 - 1994

N2 - This study examines the effect of ethanol (ETOH) exposure and nutrient restriction on the release of insulin-like growth factor (IGF)-II from 18- and 20-day explanted fetal organs. Fetuses were exposed to ETOH (E) in utero by feeding dams a 36% (calories derived from ETOH: 6.6% v/v) ETOH liquid diet. Control fetuses were offsprings of dams either pair-fed (P) a control liquid diet or ad libitum (A) fed a standard pelleted lab chow. Brain, heart, kidney, liver, lung, muscle, and placenta of fetuses from the same litter were pooled and explanted, and IGF-II concentration in explanted media was analyzed by radioimmunoassay. Maternal and fetal weights were determined during pregnancy and at sacrifice, respectively, to evaluate the influence of ETOH on growth. Both maternal and fetal weights were substantially reduced by ETOH on 18 and 20 days of gestation compared with both A and P controls. At 18 days of gestation, E fetuses (1.33 ± 0.03 g) weighed less than either A (1.47 ± 0.03 g) or P (1.54 ± 0.04 g) fetuses. By 20 days, A mean fetal weight (4.19 ± 0.23 g) was significantly greater than both P (3.74 ± 0.06 g) and E (3.28 ± 0.06 g) fetuses. IGF-II concentration in media from 18-day fetal explants was highest from E (brain, heart, liver, and placenta) and P tissues (kidney, lung, and muscle). IGF-II in media from A tissues (except placenta) was lower than both E and P levels. A significant difference between treatments occurred in heart. By 20 days, IGF-II levels were highest in media from all A tissues (except placenta). IGF-II in media from E tissues (except lung) was lower than those from P tissues. A significant difference between treatments occurred in the brain. With regard to the developmental pattern, IGF-II release generally increased between 18 and 20 days of gestation, with the greatest increases occurring in A tissues. Increased secretion by P tissues was greater than that by corresponding E tissues, and tended to follow the A trend. On the other hand, E brain, kidney, and placenta released only slightly more IGF-II at 20 days compared to 18 days, whereas E heart, liver, lung, and muscle released slightly less hormone. This study suggests that even moderate nutrient deprivation influences the pattern of IGF-II release from fetal organs, even though there is only a small decrease in overall body size. At the same level of nutrient deprivation, ETOH more dramatically alters both fetal weight and the pattern of IGF-II release. Because IGFs are autocrine/paracrine factors that influence growth, differentiation, and function, the reduced availability of IGF-II may be one of the factors contributing to ETOH-induced growth retardation and impaired functional capacity of some organ systems.

AB - This study examines the effect of ethanol (ETOH) exposure and nutrient restriction on the release of insulin-like growth factor (IGF)-II from 18- and 20-day explanted fetal organs. Fetuses were exposed to ETOH (E) in utero by feeding dams a 36% (calories derived from ETOH: 6.6% v/v) ETOH liquid diet. Control fetuses were offsprings of dams either pair-fed (P) a control liquid diet or ad libitum (A) fed a standard pelleted lab chow. Brain, heart, kidney, liver, lung, muscle, and placenta of fetuses from the same litter were pooled and explanted, and IGF-II concentration in explanted media was analyzed by radioimmunoassay. Maternal and fetal weights were determined during pregnancy and at sacrifice, respectively, to evaluate the influence of ETOH on growth. Both maternal and fetal weights were substantially reduced by ETOH on 18 and 20 days of gestation compared with both A and P controls. At 18 days of gestation, E fetuses (1.33 ± 0.03 g) weighed less than either A (1.47 ± 0.03 g) or P (1.54 ± 0.04 g) fetuses. By 20 days, A mean fetal weight (4.19 ± 0.23 g) was significantly greater than both P (3.74 ± 0.06 g) and E (3.28 ± 0.06 g) fetuses. IGF-II concentration in media from 18-day fetal explants was highest from E (brain, heart, liver, and placenta) and P tissues (kidney, lung, and muscle). IGF-II in media from A tissues (except placenta) was lower than both E and P levels. A significant difference between treatments occurred in heart. By 20 days, IGF-II levels were highest in media from all A tissues (except placenta). IGF-II in media from E tissues (except lung) was lower than those from P tissues. A significant difference between treatments occurred in the brain. With regard to the developmental pattern, IGF-II release generally increased between 18 and 20 days of gestation, with the greatest increases occurring in A tissues. Increased secretion by P tissues was greater than that by corresponding E tissues, and tended to follow the A trend. On the other hand, E brain, kidney, and placenta released only slightly more IGF-II at 20 days compared to 18 days, whereas E heart, liver, lung, and muscle released slightly less hormone. This study suggests that even moderate nutrient deprivation influences the pattern of IGF-II release from fetal organs, even though there is only a small decrease in overall body size. At the same level of nutrient deprivation, ETOH more dramatically alters both fetal weight and the pattern of IGF-II release. Because IGFs are autocrine/paracrine factors that influence growth, differentiation, and function, the reduced availability of IGF-II may be one of the factors contributing to ETOH-induced growth retardation and impaired functional capacity of some organ systems.

KW - Ethanol

KW - Fetal Growth

KW - Hormones

KW - IGF-II

KW - Organ Explants

UR - http://www.scopus.com/inward/record.url?scp=0028222716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028222716&partnerID=8YFLogxK

M3 - Article

C2 - 8198224

AN - SCOPUS:0028222716

VL - 18

SP - 35

EP - 41

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 1

ER -